Biblio

Found 1630 results
Filters: Keyword is Middle Aged  [Clear All Filters]
2013
Alonso-Gonzalez R, Borgia F, Diller G-P, Inuzuka R, Kempny A, Martinez-Naharro A, Tutarel O, Marino P, Wustmann K, Charalambides M et al..  2013.  Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy, and association with survival.. Circulation. 127(8):882-90.
Bastin AJ, Ostermann M, Slack AJ, Diller G-P, Finney SJ, Evans TW.  2013.  Acute kidney injury after cardiac surgery according to Risk/Injury/Failure/Loss/End-stage, Acute Kidney Injury Network, and Kidney Disease: Improving Global Outcomes classifications.. J Crit Care. 28(4):389-96.
Magro M, Girasis C, Bartorelli AL, Tarantini G, Russo F, Trabattoni D, D'Amico G, Galli M, Juame AGómez, Almeida Mde Sousa et al..  2013.  Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry.. EuroIntervention. 8(11):1259-69.
Puthucheary ZA, Rawal J, McPhail M, Connolly B, Ratnayake G, Chan P, Hopkinson NS, Padhke R, Dew T, Sidhu PS et al..  2013.  Acute skeletal muscle wasting in critical illness.. JAMA. 310(15):1591-600.
Biino G, Santimone I, Minelli C, Sorice R, Frongia B, Traglia M, Ulivi S, Di Castelnuovo A, Gögele M, Nutile T et al..  2013.  Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects' data.. PLoS One. 8(1):e54289.
Droney JM, Gretton SK, Sato H, Ross JR, Branford R, Welsh KI, Cookson W, Riley J.  2013.  Analgesia and central side-effects: two separate dimensions of morphine response.. Br J Clin Pharmacol. 75(5):1340-50.
Mack MJ, Head SJ, Holmes DR, Ståhle E, Feldman TE, Colombo A, Morice M-C, Unger F, Erglis A, Stoler R et al..  2013.  Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.. JACC Cardiovasc Interv. 6(4):344-54.
De Matteis S, Consonni D, Pesatori AC, Bergen AW, Bertazzi PAlberto, Caporaso NE, Lubin JH, Wacholder S, Landi MTeresa.  2013.  Are women who smoke at higher risk for lung cancer than men who smoke? Am J Epidemiol. 177(7):601-12.
Sarma S, Mentz RJ, Kwasny MJ, Fought AJ, Huffman M, Subačius H, Nodari S, Konstam M, Swedberg K, Maggioni AP et al..  2013.  Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial.. Eur J Heart Fail. 15(2):194-202.
Cabrita IZimbarra, Mohammed A, Layton M, Ghorashian S, Gilmore A, Cho G, Howard J, Anie KA, Desforges L, Bassett P et al..  2013.  The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom.. Br J Haematol. 162(3):400-8.
Lanfear DE, Sabbah HN, Goldsmith SR, Greene SJ, Ambrosy AP, Fought AJ, Kwasny MJ, Swedberg K, Yancy CW, Konstam MA et al..  2013.  Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.. Circ Heart Fail. 6(1):47-52.
Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S, Morarji K, Brown TDH, Ismail NA, Dweck MR et al..  2013.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.. JAMA. 309(9):896-908.
McMurray JJV, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M et al..  2013.  Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).. Eur J Heart Fail. 15(3):334-41.
Mosenzon O, Raz I, Scirica BM, Hirshberg B, Stahre CI, Steg PG, Davidson J, Ohman P, Price DL, Frederich B et al..  2013.  Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)-TIMI 53 trial.. Diabetes Metab Res Rev. 29(5):417-26.
Zoumot Z, Kemp SV, Caneja C, Singh S, Shah PL.  2013.  Bronchoscopic intrabullous autologous blood instillation: a novel approach for the treatment of giant bullae.. Ann Thorac Surg. 96(4):1488-91.
Langley RE, Cafferty FH, Alhasso AA, Rosen SD, Sundaram SKanaga, Freeman SC, Pollock P, Jinks RC, Godsland IF, Kockelbergh R et al..  2013.  Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09).. Lancet Oncol. 14(4):306-16.
Starke RD, Paschalaki KE, Dyer CEF, Harrison-Lavoie KJ, Cutler JA, McKinnon TAJ, Millar CM, Cutler DF, Laffan MA, Randi AM.  2013.  Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.. Blood. 121(14):2773-84.
Mehran R, Baber U, Steg PGabriel, Ariti C, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ et al..  2013.  Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.. Lancet. 382(9906):1714-22.
Malcolme-Lawes LC, Lim PBoon, Wright I, Kojodjojo P, Koa-Wing M, Jamil-Copley S, Dehbi H-M, Francis DP, D Davies W, Peters NS et al..  2013.  Characterization of the left atrial neural network and its impact on autonomic modification procedures.. Circ Arrhythm Electrophysiol. 6(3):632-40.
Wong MGeot, Perkovic V, Woodward M, Chalmers J, Li Q, Hillis GS, Azari DYaghobian, Jun M, Poulter N, Hamet P et al..  2013.  Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus.. Kidney Int. 83(2):278-84.
Diletti R, Farooq V, Girasis C, Bourantas C, Onuma Y, Heo JHo, Gogas BD, van Geuns R-J, Regar E, De Bruyne B et al..  2013.  Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSO Heart. 99(2):98-105.
Vranckx P, McFadden E, Cutlip DE, Mehran R, Swart M, Kint PP, Zijlstra F, Silber S, Windecker S, Serruys PWCJ.  2013.  Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation.. Contemp Clin Trials. 34(1):53-9.
Silber S, Serruys PW, Leon MB, Meredith IT, Windecker S, Neumann F-J, Belardi J, Widimsky P, Massaro J, Novack V et al..  2013.  Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program.. JACC Cardiovasc Interv. 6(4):357-68.
Diletti R, García-García HM, Bourantas CV, van Geuns RJan, Van Mieghem NM, Vranckx P, Zhang Y-J, Farooq V, Iqbal J, Wykrzykowska JJ et al..  2013.  Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial.. Heart. 99(17):1267-74.
Ambrosy AP, Vaduganathan M, Mentz RJ, Greene SJ, Subačius H, Konstam MA, Maggioni AP, Swedberg K, Gheorghiade M.  2013.  Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) t. Am Heart J. 165(2):216-25.

Pages